Publications by the researcher in collaboration with Ángel Manuel Gil Agudo (2)

2024

  1. Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury

    Spinal Cord

2019

  1. Documento de consenso espaÑol para el diagnÓstico, el tratamiento y el manejo de la vejiga neurÓgena

    Archivos Espanoles de Urologia, Vol. 72, Núm. 5, pp. 483-499